KYT Dental Services
Sirolimus · Mouth ulcers

Sirolimus and mouth ulcers

Quick answer

Sirolimus is one of the most common medication causes of recurrent aphthous-like mouth ulcers, affecting up to 60 percent of patients on the drug. The ulcers tend to be painful, recurrent, and can significantly affect eating and quality of life. They respond well to topical treatments and to dose reduction, but rarely resolve fully while the medication is continued. For transplant patients, the conversation is about managing the ulcers rather than stopping sirolimus.

The mechanism
Why sirolimus causes recurrent ulcers

Sirolimus is an mTOR inhibitor. It blocks a signaling pathway (mTOR) that drives cell growth and protein synthesis. This makes it useful for preventing organ transplant rejection and for some cancers. The downside is that the same pathway is essential for the rapidly dividing cells of the mouth lining, which need to replace themselves every 7 to 14 days. When mTOR is inhibited, the lining cannot keep up, and small areas of breakdown develop into painful aphthous-like ulcers.

The ulcers are different in pattern from chemo-related mucositis. They tend to be discrete, well-defined ulcers (similar to ordinary canker sores in appearance) rather than diffuse mucositis. They favor the inner cheeks, lips, and tongue. They are often painful out of proportion to their size and can interfere significantly with eating.

The rate of ulcers is dose-related. Higher sirolimus doses produce more ulcers; reducing the dose often improves them. Some transplant patients can be managed on lower sirolimus doses with another immunosuppressant added (typically tacrolimus or mycophenolate) rather than fully stopping sirolimus. The decision is the transplant team's, balancing rejection risk against quality of life.

Practical steps
What to do about sirolimus ulcers
  • Tell your transplant team or prescribing physician. They can monitor sirolimus blood levels and consider whether the dose needs adjustment.
  • Use a soft-bristle toothbrush and brush gently around active ulcers.
  • Avoid alcohol-containing mouthwash, which burns ulcers and slows healing. Saltwater rinses (one teaspoon in a cup of warm water) several times a day are gentler.
  • Topical corticosteroid gel (triamcinolone in Orabase, dexamethasone rinse) applied to ulcers significantly reduces pain and speeds healing. Your dentist or physician can prescribe these.
  • Avoid spicy, acidic, or sharp foods during active ulcers. Smooth, room-temperature foods are easier.
  • Some patients benefit from a magic mouthwash (compounded rinse with anesthetic, antifungal, and antihistamine). Your dentist can write the prescription.
Red flags
When to call your dentist
  • Recurrent ulcers that come back within weeks of healing.
  • Painful ulcers that prevent you from eating or drinking adequately.
  • Ulcers that grow larger over time instead of healing.
  • Widespread sores covering large areas of the cheek, tongue, or palate.
  • Signs of infection on top of ulcers (white patches, increased pain, fever).
Common questions
What patients ask about Sirolimus (Rapamune) and mouth ulcers.
How common are mouth ulcers on sirolimus?
Very common. Estimates range from 25 to 60 percent of patients on sirolimus, depending on dose and individual susceptibility. Higher doses produce more ulcers. Patients often have recurrent ulcers throughout treatment rather than isolated episodes.
Can I stop sirolimus because of the ulcers?
Not on your own. For transplant patients, sirolimus is preventing rejection of a transplanted organ. The decision to switch immunosuppressants is made with your transplant team based on overall function and quality of life. Ulcers are sometimes the trigger for switching to a different regimen, but it is a coordinated decision.
Will reducing the sirolimus dose help?
Often yes. Sirolimus ulcers are dose-related, and a small dose reduction can substantially reduce ulcer frequency and severity. Your transplant team can sometimes maintain adequate immunosuppression with a lower sirolimus dose plus another agent.
Are sirolimus ulcers the same as cold sores or canker sores?
They look similar to canker sores (aphthous ulcers) clinically but the mechanism is different. Cold sores are caused by herpes simplex virus and look different (clusters of small blisters on the lips). Canker sores are recurrent painful ulcers of unknown cause. Sirolimus ulcers resemble canker sores in appearance but are driven by the mTOR inhibition rather than the usual triggers.
Is everolimus the same as sirolimus for mouth ulcers?
Both are mTOR inhibitors and both cause mouth ulcers through the same mechanism. Everolimus is more commonly used for cancer indications and at higher relative doses, sometimes producing more severe mucositis. Sirolimus is more often a transplant medication at lower doses, producing the recurrent aphthous-like pattern.
Talk to a dentist about your case
Bring your medication list to your visit.

General guidance is a starting point. Your specific dental plan depends on your medical history, your other medications, and what your mouth looks like in person. Schedule a consultation and we’ll walk through it.

Schedule a consultationCall (833) 598-3368

Reviewed by Dr. Isaac Sun, DDS.

This page is general information, not medical advice. Do not start, stop, or change any medication based on what you read here. Talk to your prescribing physician and your dentist about your specific situation.